Clinical Trial Update: Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two preemptive strategies to prevent panitumumab-related skin toxicity and assessing quality of life in patients with Ras-wildtype color…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Ras-wildtype Colorectal Cancer | Phase 2 | Status: COMPLETED